Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pingchuan Ma, Jingmei Li, Yan Gao, Jieping Wu, Ke Men, Chunjie Li, Yi Men & Xingmei Duan. (2022) Local and Systemic Delivery of the BimS Gene Nano-Complex for Efficient Oral Squamous Cell Carcinoma Therapy. International Journal of Nanomedicine 17, pages 2925-2941.
Read now
Read now
Ilia Villate-Beitia, Jon Zarate, Gustavo Puras & José Luis Pedraz. (2017) Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis. Drug Development and Industrial Pharmacy 43:7, pages 1071-1081.
Read now
Read now
Saúl Abenhamar Navarro, Esmeralda Carrillo, Carmen Griñán-Lisón, Ana Martín, Macarena Perán, Juan Antonio Marchal & Houria Boulaiz. (2016) Cancer suicide gene therapy: a patent review. Expert Opinion on Therapeutic Patents 26:9, pages 1095-1104.
Read now
Read now
Articles from other publishers (25)
Alireza Shahryari, Zahra Nazari, Marie Saghaeian Jazi, Fatemeh Hashemi-Shahraki, Katharina Wißmiller, Weiwei Xu, Ingo Burtscher & Heiko Lickert. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
326
368
.
Yi Li, Wei Guo, Xiuqin Li, Jianguo Zhang, Moyi Sun, Zhangui Tang, Wei Ran, Kai Yang, Guilin Huang & Longjiang Li. (2021) Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers. International Journal of Oral Science 13:1.
Crossref
Crossref
Zhi Jie Li, Qian Qian Yang & You Lang Zhou. (2021) Basic Research on Tendon Repair: Strategies, Evaluation, and Development. Frontiers in Medicine 8.
Crossref
Crossref
Zhe Liu, Douglas R. Hurst, Xing Qu, Li-Guang Lu, Chen-Zhou Wu, Yu-Yu Li & Yi Li. (2020) Re-expression of DIRAS3 and p53 induces apoptosis and impaired autophagy in head and neck squamous cell carcinoma. Military Medical Research 7:1.
Crossref
Crossref
Mubalake Abudoureyimu, Yongting Lai, Chuan Tian, Ting Wang, Rui Wang & Xiaoyuan Chu. (2019) Oncolytic Adenovirus—A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC. Frontiers in Oncology 9.
Crossref
Crossref
Alireza Shahryari, Marie Saghaeian Jazi, Saeed Mohammadi, Hadi Razavi Nikoo, Zahra Nazari, Elaheh Sadat Hosseini, Ingo Burtscher, Seyed Javad Mowla & Heiko Lickert. (2019) Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders. Frontiers in Genetics 10.
Crossref
Crossref
Mingjuan Wang, Yanling Hong, Qiang Feng, Xinyan Pan, Shuling Song, Jing Cui, Jin Lei, Hong Fang & Julun Yang. (2018) Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression. Molecular Therapy - Oncolytics 11, pages 90-101.
Crossref
Crossref
Guoying Zou, Biqiong Ren, Yi Liu, Yin Fu, Pan Chen, Xiayu Li, Shudi Luo, Junyu He, Ge Gao, Zhaoyang Zeng, Wei Xiong, Guiyuan Li, Yumei Huang, Keqian Xu & Wenling Zhang. (2018) Inhibin B suppresses anoikis resistance and migration through the transforming growth factor‐β signaling pathway in nasopharyngeal carcinoma. Cancer Science 109:11, pages 3416-3427.
Crossref
Crossref
Joana R. Góis, Fábio Reis, Ana M. Almeida, Patrícia Pereira, Fani Sousa, Arménio C. Serra & Jorge F.J. Coelho. (2018) Preparation of well-defined brush-like block copolymers for gene delivery applications under biorelevant reaction conditions. Colloids and Surfaces B: Biointerfaces 169, pages 107-117.
Crossref
Crossref
Sergiu Chira, Diana Gulei, Amin Hajitou & Ioana Berindan-Neagoe. (2018) Restoring the p53 ‘Guardian’ Phenotype in p53-Deficient Tumor Cells with CRISPR/Cas9. Trends in Biotechnology 36:7, pages 653-660.
Crossref
Crossref
Shao Wen Xiao, Yi-Zhi Xu, Bu-Fan Xiao, Jing JiangChang-Qing Liu, Zhi-wei Fang, Dong-Ming Li, Xiao Fan Li, Yong Cai, Yong Heng Li, Yan Sun, Xing Su, Guang-Ying Zhu & Shan Wen Zhang. (2018) Recombinant Adenovirus-p53 Gene Therapy for Advanced Unresectable Soft-Tissue Sarcomas. Human Gene Therapy 29:6, pages 699-707.
Crossref
Crossref
Wei-Wei ZhangLongjiang LiDinggang LiJiliang LiuXiuqin LiWei LiXiaolong XuMichael J. ZhangLois A. ChandlerHong LinAiguo HuWei XuDominic Man-Kit Lam. (2018)
The First Approved Gene Therapy Product for Cancer Ad-
p53
(Gendicine): 12 Years in the Clinic
. Human Gene Therapy 29:2, pages 160-179.
Crossref
Crossref
Yu XiaZhenhua DuXinyan WangXiuqin Li. (2018)
Treatment of Uterine Sarcoma with rAd-p53 (Gendicine) Followed by Chemotherapy: Clinical Study of
TP53
Gene Therapy
. Human Gene Therapy 29:2, pages 242-250.
Crossref
Crossref
Zi J. WuFeng R. TangZhao-Wu MaXiao-Chun PengYing XiangYanling ZhangJingbo KangJiafu JiXiao Q. LiuXian-Wang WangHong-Wu XinBo X. Ren. (2018) Oncolytic Viruses for Tumor Precision Imaging and Radiotherapy. Human Gene Therapy 29:2, pages 204-222.
Crossref
Crossref
Xiaoni Liu, Jianji Xu, Shuang Wang, Xiaoxiao Yu, Boxin Kou, Mengyin Chai, Yunjin Zang & Dexi Chen. (2017) Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo. International Journal of Oncology 51:4, pages 1291-1299.
Crossref
Crossref
H-X Deng, Y Wang, Q-r Ding, D-l Li & Yu-quan Wei. (2017) Gene therapy research in Asia. Gene Therapy 24:9, pages 572-577.
Crossref
Crossref
Justin L. MadrigalRoberta StilhanoEduardo A. Silva. (2017) Biomaterial-Guided Gene Delivery for Musculoskeletal Tissue Repair. Tissue Engineering Part B: Reviews 23:4, pages 347-361.
Crossref
Crossref
Cody S. Lee, Elliot S. Bishop, Ruyi Zhang, Xinyi Yu, Evan M. Farina, Shujuan Yan, Chen Zhao, Zongyue Zeng, Yi Shu, Xingye Wu, Jiayan Lei, Yasha Li, Wenwen Zhang, Chao Yang, Ke Wu, Ying Wu, Sherwin Ho, Aravind Athiviraham, Michael J. Lee, Jennifer Moriatis Wolf, Russell R. Reid & Tong-Chuan He. (2017) Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes & Diseases 4:2, pages 43-63.
Crossref
Crossref
Bo Li, Ning Gao, Zhuang Zhang, Qian‐Ming Chen, Long‐Jiang Li & Yi Li. (2017) Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China. Genes 8:3, pages 85.
Crossref
Crossref
Wen-Shu Ma, Jing-Guang Ma & Li-Na Xing. (2017) Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment of recurrent nasopharyngeal carcinoma. Anti-Cancer Drugs 28:2, pages 230-236.
Crossref
Crossref
Rong Biaoxue, Pan Hui, Gao Wenlong & Yang Shuanying. (2016) Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion. Scientific Reports 6:1.
Crossref
Crossref
Tetsuya Ishii. (2016) Somatic Genome Editing for Health: Disease Treatments and Beyond. Current Stem Cell Reports 2:4, pages 313-320.
Crossref
Crossref
Li-Gang Chen, Yuan-Sheng Liu, Tang-Hui Zheng, Xu Chen, Ping Li, Chuan-Xing Xiao & Jian-Lin Ren. (2016) Therapeutic targeting of liver cancer with a recombinant DNA vaccine containing the hemagglutinin-neuraminidase gene of Newcastle disease virus via apoptotic-dependent pathways. Oncology Letters 12:5, pages 3344-3350.
Crossref
Crossref
Amir Fakhari & J. Anand Subramony. (2015) Engineered in-situ depot-forming hydrogels for intratumoral drug delivery. Journal of Controlled Release 220, pages 465-475.
Crossref
Crossref
YAN-FANG GAO, XUE-NI WEI, XIAO-LEI YE, GUO-BIN WENG, YI-CHEN CHEN, YA-RONG ZHAO & HUI JI. (2015) Anticancer activity of stoppin based on a novel peptide delivery system. Molecular Medicine Reports 12:4, pages 5437-5442.
Crossref
Crossref